Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.2400 (6.37%) ($107.8600 - $116.2400) on Fri. Jun. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.17% (three month average) | RSI | 68 | Latest Price | $116.2400(6.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.3% a day on average for past five trading days. | Weekly Trend | LGND declines -1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -2.085% in a week (0% probabilities). VIXM(-23%) UUP(-17%) VXX(-15%) UNG(-3%) IYT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.085% (StdDev 4.17%) | Hourly BBV | 0 () | Intraday Trend | 5.2% | | | |
|
5 Day Moving Average | $111.84(3.93%) | 10 Day Moving Average | $114.12(1.86%) | 20 Day Moving Average | $112.06(3.73%) | To recent high | -6% | To recent low | 74% | Market Cap | $1.868b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |